Israel Englander Surface Oncology, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.61 - $1.03 $2,577 - $4,351	4,225 Added 1.02%	419,495 $293,000
Q4 2022 Feb 14, 2023	BUY	$0.62 - $1.21 $25,891 - $50,529	41,760 Added 11.18%	415,270 $341,000
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $343,640 - $687,281	-327,277 Reduced 46.7%	373,510 $388,000
Q2 2022 Aug 15, 2022	BUY	$1.42 - $3.15 $995,117 - $2.21 Million	700,787 New	700,787 $1.15 Million
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $58,808 - $112,735	-22,192 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $247,908 - $414,054	-52,412 Reduced 70.25%	22,192 $106,000
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $384,956 - $595,339	74,604 New	74,604 $565,000
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $883,953 - $1.25 Million	-137,047 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $391,413 - $746,114	-53,988 Reduced 28.26%	137,047 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $1.31 Million - $2 Million	191,035 New	191,035 $1.77 Million
Q3 2020 Nov 16, 2020	SELL	$5.06 - $7.23 $335,088 - $478,792	-66,223 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.57 - $6.56 $329,985 - $1.38 Million	-210,182 Reduced 76.04%	66,223 $434,000
Q1 2020 May 14, 2020	SELL	$1.44 - $3.95 $32,293 - $88,582	-22,426 Reduced 7.5%	276,405 $517,000
Q4 2019 Feb 14, 2020	SELL	$1.17 - $2.33 $223,856 - $445,798	-191,330 Reduced 39.03%	298,831 $562,000
Q3 2019 Nov 14, 2019	SELL	$1.4 - $2.84 $80,238 - $162,768	-57,313 Reduced 10.47%	490,161 $696,000
Q2 2019 Aug 15, 2019	BUY	$2.75 - $4.89 $1.5 Million - $2.66 Million	544,253 Added 16897.02%	547,474 $1.54 Million
Q2 2019 Aug 14, 2019	SELL	$2.75 - $4.89 $917,394 - $1.63 Million	-333,598 Reduced 99.04%	3,221 $3.55 Million
Q1 2019 May 14, 2019	SELL	$4.11 - $5.88 $25,592 - $36,614	-6,227 Reduced 1.82%	336,819 $1.61 Million
Q4 2018 Feb 14, 2019	SELL	$3.65 - $10.69 $738,935 - $2.16 Million	-202,448 Reduced 37.11%	343,046 $1.46 Million
Q3 2018 Nov 14, 2018	BUY	$8.92 - $17.83 $94,935 - $189,764	10,643 Added 1.99%	545,494 $5.97 Million
Q2 2018 Aug 14, 2018	BUY	$12.83 - $17.41 $6.86 Million - $9.31 Million	534,851 New	534,851 $8.72 Million

Others Institutions Holding SURF

# of Institutions

Shares Held

315K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

171K
Shares

$0
0.24% of portfolio
Kingsbury Capital Investment Advisors LLC Evanston, IL

144K
Shares

$0
0.23% of portfolio

View Full List

About Surface Oncology, Inc.

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

More about SURF

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account